Engraftment of Genetically Engineered Amniotic Epithelial Cells Corrects Lysosomal Storage in Multiple Areas of the Brain in Mucopolysaccharidosis Type VII Mice

This publication has 24 references indexed in Scilit:

• Adenovirus-Mediated Gene Therapy for Mucopolysaccharidosis VII: Involvement of Cross-Correction in Wide-Spread Distribution of the Gene Products and Long-Term Effects of CTLA-4Ig Coexpression
  Molecular Therapy, 2000
• Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease
  Proceedings of the National Academy of Sciences, 1999
• Extensiveβ-Glucuronidase Activity in Murine Central Nervous System after Adenovirus-Mediated Gene Transfer to Brain
  Human Gene Therapy, 1998
• Evidence for synthesis and release of catecholamines by human amniotic epithelial cells
  NeuroReport, 1997
• Evidence for active acetylcholine metabolism in human amniotic epithelial cells: applicable to intracerebral allografting for neurologic disease
  Neuroscience Letters, 1997
• Decreased lysosomal storage in the adult MPS VII mouse brain in the vicinity of grafts of retroviral vector-corrected fibroblasts secreting high levels of β-glucuronidase
  Nature Medicine, 1997
• Expression of markers for both neuronal and glial cells in human amniotic epithelial cells
  Neuroscience Letters, 1996
• Immunostaining of human amniotic epithelial cells: Possible use as a transgene carrier in gene therapy for inborn errors of metabolism
  Cell Transplantation, 1995
• Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency.
  Journal of Clinical Investigation, 1989
• Beta glucuronidase deficiency: Report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis
  The Journal of Pediatrics, 1973